StockWatch
·

BLISS GVS PHARMA LTD. Q2 FY26 Results

BLISSGVSQ2 FY26 Results
Filing
MetricValue ( Cr)Q1 FY26Q2 FY25
Revenue244.4017.8%12.3%
Total Income264.588.9%18.8%
Expenditure223.9424.5%19.8%
PBT40.6335.6%13.8%
Net Profit28.5935.6%11.3%
OPM12.99%6.93pp3.87pp
NPM10.81%7.45pp0.73pp
EPS2.5836.8%11.7%
View full financials

Informational and educational content only. Not investment advice.